Osenvelt — Medica
Multiple myeloma – prevention of skeletal-related events
Initial criteria
- Patient is age ≥ 18 years
- Medication is prescribed by or in consultation with a hematologist or an oncologist
Approval duration
1 year
Multiple myeloma – prevention of skeletal-related events
1 year